Category: by reason for retraction

Nutritionist group pulls position statement on vegetarian diets for “inaccuracies and omissions”

Screen Shot 2015-10-16 at 11.57.38 AMWhat are the specific health benefits to skipping out on meat? We’re not totally sure, after the largest organization for nutrition professionals pulled its 2015 position statement on this issue only weeks after publishing it in the Journal of the Academy of Nutrition and Dietetics.

The “Position of the Academy of Nutrition and Dietetics: Vegetarian Diets” was removed earlier this year for “inaccuracies and omissions critical to the paper” — and the first author wasn’t told what they were. A “major revision” is forthcoming.

Here’s the removal note from the journal for the 2015 version:

Continue reading Nutritionist group pulls position statement on vegetarian diets for “inaccuracies and omissions”

Heart researcher who faked patient data gets 4th retraction

XLargeThumb.00004872-201512000-00000.CVA heart researcher who fabricated patient records for her studies on the blood pressure medication ramipril has earned her fourth retraction, and more are apparently on the way.

For readers who are new to this case: Things first unraveled for Anna Ahimastos when a subanalysis of a JAMA clinical trial revealed “anomalies,” triggering an investigation. After Ahimastos admitted to fabricating patient data, that JAMA paper and two others — including a small trial in Annals of Internal Medicine — were pulled. A spokesperson for her former employer, Baker IDI Heart & Diabetes Institute, told us last week that they have requested more retractions:

Five papers and one letter are in the process of being retracted.

The Annals and this latest paper are included in the five papers, so we expect to see Continue reading Heart researcher who faked patient data gets 4th retraction

A bacterium may be anti-fungal, but it’s not anti-retraction

6

The authors of a paper on an anti-fungal bacterium couldn’t ward off a very common problem: plagiarism. The people credited on the paper, published in Applied Microbiology and Biotechnology, apparently weren’t the original authors, according to the retraction note.

We’re not sure who the original authors are. The retraction note doesn’t elaborate much:

Continue reading A bacterium may be anti-fungal, but it’s not anti-retraction

Psychologist Jens Forster settles case by agreeing to 2 retractions

forster-j-a
Jens Förster

Following questions about the veracity of multiple papers by his former employer, high-profile social psychologist Jens Förster has agreed to retract two papers as part of a deal with the German Society for Psychology (DGPs).

Last year, Förster had a paper retracted at the request of his former employer, the University of Amsterdam (UvA). In May, an investigation commissioned by UvA found that many of his experiments looked “too good to be true,” and eight papers showed strong signs of “low veracity.”

Just two of those papers are acknowledged in the settlement of a case by the DGPs against Förster, who currently works at Ruhr University Bochum. Here’s a translation of a notice from the DGPs from One Hour Translation:

Continue reading Psychologist Jens Forster settles case by agreeing to 2 retractions

When a paper is retracted, so is its previous correction–sometimes

1-s2.0-S0968089612X0018X-cov150hSometimes, the path to correcting the scientific record takes a few turns. In the case of a paper about a new cancer compound, authorship issues led to a correction and, ultimately, a retraction — along with a double-back to retract the earlier correction.

We reported on the first part of the story back in January: A 2011 paper that described a novel compound that could work as a drug for the side effects of chemotherapy was corrected in 2012 to add additional authors. But once the authors realized their supposedly novel compound had actually been synthesized by another author, they decided to retract the paper from Bioorganic and Medicinal Chemistry earlier this year, concluding “these facts made the paper inappropriate and unfaithful.”

Apparently, around the same time, the authors decided to retract the earlier correction, as well:

Continue reading When a paper is retracted, so is its previous correction–sometimes

Genetics paper retracted for using material “without permission and/or proper reference”

Molecular Genetics and GenomicsA review article about a tool used to link genes to traits and behaviors has been retracted for including content “without permission and/or proper reference.”

Corresponding author Ali Masoudi-Nejad at the University of Tehran told us that the retraction occurred mostly because the paper included many figures and tables from other sources, and he didn’t realize they needed to seek permission from both the author and the copyright-holder (ie, the publisher). He added that he doubts he is the only one to make this mistake: Continue reading Genetics paper retracted for using material “without permission and/or proper reference”

BMC retracts paper by scientist who banned use of his software by immigrant-friendly countries

Screen Shot 2015-11-10 at 12.24.42 PMA BioMed Central journal has pulled the paper of a scientist who decided to prohibit countries that are friendly to immigrants from using his software.

Recently, German scientist Gangolf Jobb declared that starting on October 1st scientists working in countries that are, in his opinion, too welcoming to immigrants — including Great Britain, France and Germany — could no longer use his Treefinder software, which creates trees showing potential evolutionary relationships between species. He’d already banned its use by U.S. scientists in February, citing the country’s “imperialism.” Last week, BMC Evolutionary Biology pulled the paper describing the software, noting it now “breaches the journal’s editorial policy on software availability.”

Many scientists have used Jobb’s software: The BMC paper that describes it, “TREEFINDER: a powerful graphical analysis environment for molecular phylogenetics,” has been cited 745 times since it was published in 2004, according to Thomson Scientific’s Web of Knowledge.

Jobb told Retraction Watch that the software is still available to any scientist willing to travel to non-banned countries, and that he does not care about the retraction: Continue reading BMC retracts paper by scientist who banned use of his software by immigrant-friendly countries

Can linguistic patterns identify data cheats?

JLAPSCunning science fraudsters may not give many tells in their data, but the text of their papers may be a tipoff to bad behavior.

That’s according to a new paper in the Journal of Language and Social Psychology by a pair of linguists at Stanford University who say that the writing style of data cheats is distinct from that of honest authors. Indeed, the text of science papers known to contain fudged data tends to be more opaque, less readable and more crammed with jargon than untainted articles.

The authors, David Markowitz and Jeffrey Hancock, also found that papers with faked data appear to be larded up with references – possibly in an attempt to make the work more cumbersome for readers to wade through, or to tart up the manuscript to make it look more impressive and substantial. As Markowitz told us: Continue reading Can linguistic patterns identify data cheats?

Intellectual property issues sink cancer paper in JACS

176 spine minimum. full size. Editor: Lingling JEM: Leslie RTP: Michael ReidThe authors of a paper on a mechanism for potential cancer therapies are retracting it after realizing they published some proprietary findings “without permission and agreement from St. Jude Children’s Research Hospital.”

According to the retraction note in Journal of the American Chemical Society, the authors included an X-ray crystal structure and data that were gathered at St. Jude’s and considered the hospital’s intellectual property. On the paper, the last author, Zhengding Su, listed an affiliation at St. Jude and Hubei University of Technology in China, along with Amersino Biodevelop Inc., based in Waterloo, Canada.

Here’s the note for “Efficient Reactivation of p53 in Cancer Cells by a Dual MdmX/Mdm2 Inhibitor:”  Continue reading Intellectual property issues sink cancer paper in JACS

“Most responsible course of action is to retract:” Duplicated images fell prostate cancer paper

International Journal of CancerA study on the cellular interactions underlying prostate cancer has been retracted after a whistleblower pointed out duplicated images in one of the paper’s figures that were “erroneously presented as unique.”

The International Journal of Cancer posted the notice in June. The authors backed the paper’s conclusions but agreed, “the most responsible course of action is to retract.”

The notice reads:

Continue reading “Most responsible course of action is to retract:” Duplicated images fell prostate cancer paper